The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) closed the day trading at $25.23 down -4.50% from the previous closing price of $26.42. In other words, the price has decreased by -$4.50 from its previous closing price. On the day, 0.77 million shares were traded. OLMA stock price reached its highest trading level at $26.18 during the session, while it also had its lowest trading level at $25.1.
Ratios:
For a better understanding of OLMA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.03 and its Current Ratio is at 8.03. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for this company, Piper Sandler on January 07, 2026, initiated with a Overweight rating and assigned the stock a target price of $40.
On October 08, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $20.
Citigroup reiterated its Buy rating for the stock on August 12, 2025, while the target price for the stock was revised from $20 to $21.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 20 ’26 when Harmon Cyrus sold 10,000 shares for $26.88 per share. The transaction valued at 268,800 led to the insider holds 727,770 shares of the business.
Harmon Cyrus bought 10,000 shares of OLMA for $268,763 on Jan 20 ’26. On Jan 14 ’26, another insider, Harmon Cyrus, who serves as the Director of the company, sold 3,489 shares for $29.12 each. As a result, the insider received 101,600 and left with 737,770 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OLMA now has a Market Capitalization of 2022434688 and an Enterprise Value of 1407807872.
Stock Price History:
The Beta on a monthly basis for OLMA is 1.91, which has changed by 3.0957794 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, OLMA has reached a high of $36.26, while it has fallen to a 52-week low of $2.86. The 50-Day Moving Average of the stock is -0.65%, while the 200-Day Moving Average is calculated to be 130.87%.
Shares Statistics:
Over the past 3-months, OLMA traded about 3.74M shares per day on average, while over the past 10 days, OLMA traded about 1267650 shares per day. A total of 68.65M shares are outstanding, with a floating share count of 65.97M. Insiders hold about 16.14% of the company’s shares, while institutions hold 75.60% stake in the company. Shares short for OLMA as of 1767139200 were 10399087 with a Short Ratio of 2.78, compared to 1764288000 on 10810748. Therefore, it implies a Short% of Shares Outstanding of 10399087 and a Short% of Float of 14.069999999999999.
Earnings Estimates
Its stock is currently analyzed by 9.0 different market analysts. The consensus estimate for the next quarter is -$0.53, with high estimates of -$0.43 and low estimates of -$0.62.
Analysts are recommending an EPS of between -$1.8 and -$2.22 for the fiscal current year, implying an average EPS of -$1.92. EPS for the following year is -$2.31, with 8.0 analysts recommending between -$1.79 and -$2.71.
